According to the World Health Organization, cardiovascular disease is the main cause of death and is expected to cause more than 23.6 million deaths till 2030. 1 The incidence of acute coronary syndromes (ACS) is lower in women than men in all ages. 2 While the overall cardiovascular mortality is higher in men than women, this difference appears to be eliminated in the last decade as men show a decrease with corresponding female increased mortality associated with coronary artery disease. 3, 4 However, the effect of the acute myocardial infarction (AMI) in younger women 5 has increased and it may exhibit a higher risk of death compared to young men. 6 Generally women presented more often with AMI without ST elevation (NSTE-ACS) or unstable angina and less often with ST segment elevation (STEMI) compared to men. 7 From pathophysiological aspect the use of newer invasive and noninvasive imaging techniques such as coronary artery grayscale-IVUS, VH-IVUS, OCT showed differences in acute coronary events between men and women. 8 In particular, women have smaller arteries 9 and therefore smaller plaque burden required for clot coronary disease events and further may have a higher restenosis risk. 10 In addition, women have a lower plaque burden, compared to males at all ages but culprit lesions are similar in OCT in both sexes. Autopsy studies have shown that the erosion compared to the plaque rupture is the principal mechanism of coagulation and erosion occurs more often in younger women. 11 In women <65 years old the not culprit lesions are fewer and with less focal atheromatosis and plaque ruptures in relation to men, while the difference is smoother after 65 years. 12 Regarding the nonatherosclerotic mechanisms of the ACS seems that women have often microvascular and endothelial dysfunction resulting in recurrent angina, hospitalizations and heart failure. 13 Women with acute myocardial infarction (AMI) with elevation of the ST (STEMI) compared to men are older, more often have hypertension and diabetes and usually arrive later at hospital 2 where exhibit atypical symptoms such as vomiting, breathlessness, neck pain, palpitations. 2 Additionally women have more frequently angina or heart failure, and worse Killip class and compare to men develop often cardiogenic shock, pulmonary edema, sinus arrest, stroke, mechanical complications and major bleeding events even after statistical adjustment to age and comorbidities. Instead men often exhibit malignant ventricular arrhythmias and sudden cardiac death. 2 When women are diagnosed with STEMI receive less often proper therapy since the era of thrombolysis 14 including admission into intensive care unit, 15 aspirin and thrombolysis. 16 Primary angioplasty which is the best method of revascularisation for both men and women accompanied by higher rates of vascular complications in women. 16, 17 Younger women with STEMI show higher rates of inhospital mortality than men, even after adjusting for the medical history, clinical severity and early treatment, while women <55 years old presented without chest pain show higher inhospital mortality compared to men.
18e20 Possible explanations of the higher short-term mortality of young women seem to be the highest pre-hospital mortality of men, most cardiovascular risk factors, most comorbidities in women with ACS, less typical symptoms and more doubtful diagnoses leading to suboptimal treatment, omission and failure to recognize in time of the basis of the guidelines symptoms and a lower percentage of treatments. As regards the long-term survival although less studied appears that women have better results after STEMI compared to men. 21 Women with AMI without ST elevation (NSTE-ACS) compared with men seem to have suboptimal treatment at admission and after the hospital even though they have increased cardiovascular risk and lack of differences in guidelines. 2 The role of gender on prognosis of patients with NSTE-ACS is in doubt. Women have higher rates of nonobstructive epicardial coronary disease, compared to men, and this subpopulation shows better inhospital prognosis in both sexes compared to patients with significant atherosclerotic disease. 22 Rather worse prognosis show women with NSTE-ACS and significant epicardial coronary disease after PCI. 23 Overall, the data so far that determine the differences in the prognosis of both sexes after NSTE-ACS mainly based on statistical correlations, extent of coronary disease and maybe in a different response to antithrombotic therapeies. 24 Kragholm et al showed the reduced participation of women in clinical trials in patients with NSTE-ACS in the absence of improvement in recent years, while the treatments based on the instructions and the prognosis has improved between women. 25 Pharmaceutical treatment of AMI shows no difference in efficacy between the two sexes. Beta blockers, statins, angiotensin-converting enzyme inhibitors and antithrombotic therapy in several studies is the appropriate evidence-based treatment of acute coronary syndromes. In particular recent studies demonstrate similar efficacy of anticoagulant therapy between two sexes. 26 However female sex has been associated with increased bleeding risk 27 among patients with ACS and features an important and independent predictor of in-hospital major bleeding factor in CRUSADE bleeding score. 28, 29 Nevertheless other studies such as the ACUITY 30 33 Another explanation might be the antithrombotic treatment dosage which is not adjusted on weight and renal function affecting mainly women. 26 Thus although women treated with the same pharmacological antithrombotic treatments with men, a closer monitoring by measuring body weight and creatinine clearance and dose adjustment is needed. 26 The non-occlusive atherosclerotic disease, defined as <50% stenosis of the coronary vessel, is found in 5e20% of ACS. 34 In a recent study of patients with NSTE-ACS, the total mortality was higher in patients without obstructive coronary disease than obstructive, which was associated with higher non-cardiac mortality and reinfarction and unplanned revascularization was higher in patients with obstructive coronary artery disease. 35 An important cause of non-obstructive atherosclerosis acute coronary syndrome is the Takotsubo cardiomyopathy associated with 2e5% ACS and referred mainly in postmenopausal women after emotional or physical stress in> 80%. 36 The automatic dissection of coronary arteries (spontaneous coronary artery dissection, SCAD) is also a major cause of non-atherosclerotic coronary disease. It is a disease entity which is increasingly recognized as a common cause of AMI in young women often underdiagnosed as a cause of sudden cardiac death, ventricular tachyarrhythmia, STEMI and NSTE-ACS. 37, 38 The incidence of SCAD is uncertain but according to retrospective studies based in angiographic data ranges from 0.07 to 1.1%. 39 The first description of the disease was in 1931 by Dr Pretty who described the sudden death of a 42years old female with multi pregnancies after angina while the autopsy revealed the dissection of the right coronary artery. More than 4% of ACS and over 40% of ACS in women <55 years of age may be due to automatic dissection of coronary artery. 37 Disease entities such as Marfan syndrome, systemic lupus erythematosus, the perinatal period in> 25%, physical or emotional stress> 55% and fibromuscular dysplasia of up to 70% associated with non-atherosclerotic automatic dissection of coronary arteries. 40, 41 Moreover they have been reported familial cases according to the Mayo Clinic records and multiple arteries attact. 42 Various recurrence rates have been reported by 13% at 2 years, up to 20% after 10 years in different patients registries. 35, 43 Younger imaging techniques such as IVUS and OCT improve the diagnostic imaging of the disease and may help to guide therapeutic decisions. 37 Angiographically includes three types 1) Multiple lumens (true, psefdolumen) 2) Mild diffuse stenosis 3) Imitates atherosclerosis. 44 The therapeutic approach varies leading some investigators to promote conservative treatment compared with angioplasty in fragile coronary arteries unless acute ischemia developed. 37 In particular based on the position that the vessels of SCAD can be treated concervatively 38, 39 and in contrast with the treatment of atherosclerotic coronary artery disease by interventional cardiology becoming increasingly adopting the approach '' less is more ''. Therefore avoid coronary intervention in patients with stable SCAD with conserved flow and even with significant blockage or infraction. 41 However angioplasty or CABG remains the appropriate solution in patients clinically unstable or with complete obstruction, even in pregnant patients. 41 The rate and frequency of healing is not known. A significant percentage of patients under conservative treatment may experience disease progression and require revascularization requiring more thorough clinical monitoring of patients during acute phase. 41 Automatic dissections of other vessels are quite frequent and the risk of coronary angiography outweigh the possible benefits. Although the short-and long-term prognosis of these patients is good seems to remain the risk of major cardiovascular events 39 and would require continuous monitoring with corresponding cardiovascular imaging on clinical indications.
In conclusion, recognition and quality of care between sexes is not the same in ischemic heart disease, the presence of pathophysiological and psychosocial differences between sexes also appears to affect their prognosis after acute coronary syndrome and required greater representation of women in clinical trials acute coronary syndromes.
